Anti-inflammatory and PPAR transactivational effects of secondary metabolites from the roots of Asarum sieboldii

被引:65
作者
Quang, Tran Hong [1 ,2 ]
Ngan, Nguyen Thi Thanh [1 ]
Van Minh, Chau [2 ]
Van Kiem, Phan [2 ]
Tai, Bui Huu [1 ]
Thao, Nguyen Phuong [1 ,2 ]
Song, Seok Bean [1 ]
Kim, Young Ho [1 ]
机构
[1] Chungnam Natl Univ, Coll Pharm, Taejon 305764, South Korea
[2] VAST, Inst Marine Biochem, Hanoi, Vietnam
基金
新加坡国家研究基金会;
关键词
Asarum sieboldii; Aristolochiaceae; Lignan; Anti-inflammatory; PPAR transactivational activity; NF-KAPPA-B; ASIASARUM-HETEROTROPOIDES; CONSTITUENTS; GROWTH; LIGNAN; AMIDES; DRUGS; RADIX;
D O I
10.1016/j.bmcl.2012.01.136
中图分类号
R914 [药物化学];
学科分类号
100705 [微生物与生化药学];
摘要
Phytochemical study on the roots of Asarum sieboldii resulted in the isolation of one new compound, (1R,2S,5R,6R)-5'-O-methylpluviatilol (1) and 12 known compounds (2-13). Their structures were determined by extensive spectroscopic methods, including 1D and 2D NMR, and MS spectra. The absolute configuration of compound 1 was established using CD spectrum. Compounds 4, 5, and 12/13 significantly inhibited TNF alpha-induced NF-kappa B transcriptional activity in HepG2 cells in a dose-dependent manner, with IC50 values ranging from 6.4 to 9.4 mu M. Furthermore, the transcriptional inhibitory function of these compounds was confirmed based on decreases in COX-2 and iNOS gene expression in HepG2 cells. Compounds 1-3, 6, 7, 10, and 11 significantly activated the transcriptional activity of PPARs in a dose-dependent manner, with EC50 values ranging from 1.7 to 20.9 mu M. Compounds 7, 10, and 11 exhibited significant dose-dependent PPAR alpha transactivational activity, with EC50 values of 19.5, 15.7, and 4.0 mu M, respectively. Compounds 1, 6, 7, 10, and 11 activated PPAR gamma transcriptional activity, with EC50 values ranging from 3.6 to 22.6 mu M, whereas compounds 10 and 11 significantly increased PPAR beta(delta) transactivational activity, with EC50 values of 22.6 and 4.9 mu M, respectively. These results provide a scientific support for the use of the roots of A. sieboldii and warrant further studies to develop new agents for the prevention and treatment of the inflammatory and metabolic diseases. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2527 / 2533
页数:7
相关论文
共 32 条
[1]
The transcription factor NF-κB and human disease [J].
Baldwin, AS .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (01) :3-6
[2]
Balint B. L., 2006, Endocrine Metabolic & Immune Disorders-Drug Targets, V6, P33
[3]
Secondary metabolites of Protium heptaphyllum march [J].
Bandeira, PN ;
Pessoa, ODL ;
Trevisan, MTS ;
Lemos, TLG .
QUIMICA NOVA, 2002, 25 (6B) :1078-1080
[4]
Bankova V, 1999, FITOTERAPIA, V70, P190, DOI [10.1016/S0367-326X(98)00045-8, 10.1016/S0367-326X(98)00044-6]
[5]
PPARδ:: a dagger in the heart of the metabolic syndrome [J].
Barish, GD ;
Narkar, VA ;
Evans, RM .
JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (03) :590-597
[6]
The mechanisms of action of PPARs [J].
Berger, J ;
Moller, DE .
ANNUAL REVIEW OF MEDICINE, 2002, 53 :409-435
[7]
POLYACETYLENIC COMPOUNDS .225. FURTHER AMIDES FROM TRIBE ANTHEMIDEAE [J].
BOHLMANN, F ;
ZDERO, C ;
SUWITA, A .
CHEMISCHE BERICHTE-RECUEIL, 1974, 107 (03) :1038-1043
[8]
Cytotoxic terpenes and lignans from the roots of Ainsliaea acerifolia [J].
Choi, SZ ;
Yang, MC ;
Choi, SU ;
Lee, KR .
ARCHIVES OF PHARMACAL RESEARCH, 2006, 29 (03) :203-208
[9]
Duan H., 2010, ZHONGYAOCAI, V33, P562
[10]
PPAR agonists: multimodal drugs for the treatment of type-2 diabetes [J].
Gross, Barbara ;
Staels, Bart .
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 21 (04) :687-710